Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Revenue (QoQ) (2009 - 2026)

Analysis

Charles River Laboratories International (CRL) Revenue (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 0.83%
Mar 28, 2026 0.16%
Dec 27, 2025 -1.06%
Sep 27, 2025 -2.64%
Jun 28, 2025 4.87%
Mar 29, 2025 -1.83%
Dec 28, 2024 -0.71%
Sep 28, 2024 -1.59%
Jun 29, 2024 1.44%
Mar 30, 2024 -0.19%
Dec 30, 2023 -1.28%
Sep 30, 2023 -3.14%
Jul 1, 2023 2.97%
Apr 1, 2023 -6.41%
Dec 31, 2022 11.19%
Sep 24, 2022 1.65%
Jun 25, 2022 6.48%
Mar 26, 2022 0.98%
Dec 25, 2021 1.02%
Sep 25, 2021 -2.04%